Craig R. Rayner

Monash University AU

0000-0001-7755-6419

116

Publications

7,392

Citations

H-Index

i10-Index

2.33

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

Jian Li, Roger L. Nation, John Turnidge, Robert Milne, Kingsley Coulthard +2 more

The Lancet Infectious Diseases 2006

1,374

Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii OA

Jian Li, Craig R. Rayner, Roger L. Nation, Roxanne J. Owen, Denis Spelman +2 more

Antimicrobial Agents and Chemotherapy 2006

538

Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use Program

Mary C. Birmingham, Craig R. Rayner, Alison Meagher, Susan M. Flavin, Donald H. Batts +1 more

Clinical Infectious Diseases 2003

427

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial OA

Gilmar Reis, Eduardo Augusto dos Santos Moreira-Silva, Daniela Carla Medeiros Silva, Lehana Thabane, Aline Cruz Milagres +22 more

The Lancet Global Health 2021

399

Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa OA

Phillip J. Bergen, Jian Li, Craig R. Rayner, Roger L. Nation

Antimicrobial Agents and Chemotherapy 2006

359

Publications

116 total

Retraction notice to Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial [The Lancet Regional Health-Americas Volume 6, February 2022, 100142].

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silv, Daniela Carla Medeiros Silv, Lehana Thabane, A. C. Milagres - The Lancet Regional Health - Americas, 2025

Cited by 0 Semantic Scholar

Early Treatment with Pegylated Interferon Lambda for Covid-19 PDF

Gilmar Reis, Eduardo A.S. Moreira Silva, Daniela C. Medeiros Silva, Lehana Thabane, Vitoria H.S. Campos et al. - New England Journal of Medicine, 2023

Cited by 170 OpenAlex

Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection PDF

Beesan Tan, Nicholas Opoku, Simon K. Attah, Kwablah Awadzi, Annette C. Kuesel et al. - PLoS neglected tropical diseases, 2022

Cited by 154 OpenAlex

Issue Information

Ibrahim Eniayewu, A. Akinloye, S. Atoyebi, A. Olagunju, M. Laurenti - CPT: Pharmacometrics & Systems Pharmacology, 2022

Cited by 0 Semantic Scholar

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial PDF

Gilmar Reis, Eduardo Augusto dos Santos Moreira-Silva, Daniela Carla Medeiros Silva, Lehana Thabane, Aline Cruz Milagres et al. - The Lancet Global Health, 2021

Cited by 399 OpenAlex

How COVID-19 has fundamentally changed clinical research in global health PDF

Jay Park, Robin Mogg, Gerald E. Smith, Etheldreda Nakimuli‐Mpungu, Fyezah Jehan et al. - The Lancet Global Health, 2021

Cited by 221 OpenAlex

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers PDF

C. Glenn Begley, Mark Ashton, Jonathan B. Baell, Michael D. Bettess, Michael P. Brown et al. - Science Translational Medicine, 2021

Cited by 149 OpenAlex

A multi-center, adaptive, randomized, platform trial to evaluate the effect of repurposed medicines in outpatients with early coronavirus disease 2019 (COVID-19) and high-risk for complications: the TOGETHER master trial protocol OA

Gilmar Reis, E. A. S. M. Silva, D. Silva, Kristian Thorlund, L. Thabane - Gates Open Research, 2021

Cited by 1 Semantic Scholar

Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses PDF

Mike Bray, Craig R. Rayner, François Noël, David A. Jans, Kylie M. Wagstaff - Antiviral Research, 2020

Cited by 143 OpenAlex

Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity againstPseudomonas aeruginosain Murine Thigh and Lung Infection Models PDF

Rajesh V. Dudhani, John Turnidge, Kingsley Coulthard, Robert Milne, Craig R. Rayner et al. - Antimicrobial Agents and Chemotherapy, 2009

Cited by 196 OpenAlex

Research Topics

Influenza Virus Research Studies (37) Antibiotics Pharmacokinetics and Efficacy (30) Receptor Mechanisms and Signaling (18) Antibiotic Resistance in Bacteria (15) COVID-19 Clinical Research Studies (14)

Frequent Co-Authors

Jian Li

4 joint publications

Roger L. Nation

4 joint publications

Mary C. Birmingham

3 joint publications

Alison Meagher

3 joint publications

Jerome J. Schentag

3 joint publications

Gilmar Reis

3 joint publications

Affiliations

Monash University Malaysia

MY 2017 - 2017

Roche (Switzerland)

CH 2012 - 2007

Royal Children's Hospital

AU 2003 - 2003

Inserm

FR 2020 - 2020

Pontifícia Universidade Católica de Minas Gerais

BR 2021 - 2021

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers

Craig R. Rayner

Publication & Citation Trends

Most Cited Works

Publications

A multi-center, adaptive, randomized, platform trial to evaluate the effect of repurposed medicines in outpatients with early coronavirus disease 2019 (COVID-19) and high-risk for complications: the TOGETHER master trial protocol OA

Research Topics

Frequent Co-Authors

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back